Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection - Test2 - elhamkhani - TriplyDB

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

http://www.wikidata.org/entity/Q28258066

about

The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections Gut microbiota in autism and mood disorders Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection Fecal microbiota transplantation for the treatment of Clostridium difficile infection A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management.Advances in the Microbiome: Applications to Clostridium difficile Infection Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection The intestinal microbiome and surgical disease.Going to the Bank: Fecal Microbiota Transplantation in Pediatrics.Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.Fecal microbiota transplantation in metabolic syndrome: History, present and future.[The microbiome of the gut in critically ill patients].Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal Inflammation Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection.Breakthroughs in the treatment and prevention of Clostridium difficile infection.Fecal microbiota transplantation in children: a brief review.Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.Fecal Microbiota Therapy for Clostridium difficile Infection: A Health Technology Assessment.Systematic Review: Adverse Events of Fecal Microbiota Transplantation Antibiotics as deep modulators of gut microbiota: between good and evil.Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis.C. difficile Infection: Changing Epidemiology and Management Paradigms Fecal microbiota transplant for Clostridium difficile infection in older adults.Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders.Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation THE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIUM DIFFICILE INFECTION.The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.Management of inflammatory bowel disease with Clostridium difficile infection.The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.Therapies on the horizon for Clostridium difficile infections.

P2860

Q26748672-C6A7B9E8-E30D-4B4D-BEA3-F26E5DE27941 Q26752760-30033855-D14D-4434-B9CE-EDDF9AAFE5FC Q26772308-00A60FF0-6561-4979-9AEB-EBAC31CA4F44 Q26774688-E078920D-F486-48CD-ACC0-0F1C04B7B021 Q26783516-5342F178-9BA2-467A-8CA7-48805F99EC2A Q27335693-92C0C5C7-9070-4D5D-9BC6-581B2AF7C8E1 Q28066362-813EC631-E7CD-43FE-A07E-7BBF7B65FAC7 Q28080494-2687C561-D772-4C33-8963-CAE923504FFC Q30235446-9AD1DF43-F9EC-4EE1-9F74-0C105F1FB99B Q30235905-50470F28-F8CE-457E-9776-9E97160F8CE1 Q30240264-7FE52D5F-3325-413A-8EC7-F9A9D8109C4F Q30248605-545FE33A-3E15-465C-B9CF-73396EA0F011 Q33459504-7A57857A-A699-45FE-A0A0-7FBAB50EE3FF Q33466550-4E5414F2-1133-44FB-86A8-1224B8DA794C Q33821397-6ADD07DE-BAF6-4F22-9E46-6E214F0E9697 Q35766204-3BDF54D1-C9AF-4735-B8D3-659FFF1744E5 Q35790385-C4181836-CE2C-4C3E-A2D1-4338005F290C Q35803240-2973BA14-A610-46B6-8533-3DA78182CAFE Q35867850-A7EB7420-3C8D-466B-821F-3C5682EA705F Q35918566-1AB5360B-0517-4036-87AB-796D13FA90D8 Q35959464-532AADC2-07D8-4A46-8721-E620CA676E73 Q35979116-298ED675-03DC-4242-A8DF-7E895040355F Q36050474-ECE4D2D8-81A5-443B-84AF-98F3130DA5E9 Q36102458-93D21628-0E20-4A4C-884E-C091A31C71F1 Q36104943-2C7CC1AE-974E-469A-9306-332FA3B96841 Q36105508-BBF001E6-DD05-4761-B81D-D3B43C999C9C Q36253963-A217A978-DFD5-4C31-A7B0-C61405E5D7BA Q36404998-D1C10B5A-0480-414C-A1E8-EA0F9F17466A Q36624142-9FD9682C-B266-47D4-9E3B-DB2944B50ADD Q36752034-DEFF93DD-C807-4D07-BD7C-83C8619C04D6 Q36793818-001150A6-73DA-4E5F-A46A-99FCDFB8A98F Q36919674-A1EE3E15-09A7-43B6-99CF-579F03C2F6D4 Q37014160-D4647F1C-A225-4560-963F-679200594CE1 Q37530430-46E2681B-4B43-40C7-9F30-461BE5DE96CE Q37563802-9133128B-CB43-4962-B2EB-F1669C5603E6 Q38600245-CB88924F-80F3-4F3E-838F-07D100E9B527 Q38635974-A92D04BA-F299-4695-9612-265740ACA598 Q38658559-BF3882F8-EBC4-4A02-B54E-43BFD673AEFE Q38679612-0BC87AB4-F6B6-4A42-BEF1-EF33932B4645 Q38757930-2FB4D017-B185-4A90-BA0C-83104A524411

P2860

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

http://www.wikidata.org/entity/Q28258066

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Randomised clinical trial: fae ...... lostridium difficile infection

@ast

Randomised clinical trial: fae ...... lostridium difficile infection

@en

Randomised clinical trial: fae ...... lostridium difficile infection

@nl

type

label

Randomised clinical trial: fae ...... lostridium difficile infection

@ast

Randomised clinical trial: fae ...... lostridium difficile infection

@en

Randomised clinical trial: fae ...... lostridium difficile infection

@nl

prefLabel

Randomised clinical trial: fae ...... lostridium difficile infection

@ast

Randomised clinical trial: fae ...... lostridium difficile infection

@en

Randomised clinical trial: fae ...... lostridium difficile infection

@nl

P1433

Q28258066-531846D5-0AAA-42A7-A3A5-2803E02B18F6

P1476

Q28258066-3400D8A0-910A-4FB6-AB3E-E0F0A56D8C19

P2093

Q28258066-146E3411-7A29-4FC3-96C5-D12827B5F3A2

Q28258066-A18A8F04-9BB9-4D70-8CAC-2269998792BB

Q28258066-A319FB89-397F-43F3-BD39-9A28FB7EAB25

Q28258066-EAEA72E6-6916-460B-B0DA-42909DF9344C

Q28258066-EB4A8CEF-DB3F-4ADF-936C-BA325684CA07

P2860

Q28258066-1C6E0DC4-4117-4844-B0F2-5831A7A4DA69

Q28258066-1FA6F814-6344-4267-AF1E-771C8DC2B554

Q28258066-2AAD9399-C5A2-498D-8D8F-2524E20BE651

Q28258066-2BDC3FE1-DF65-4F27-92FB-673FC6D95B6B

Q28258066-406AAC74-7D77-4158-BA68-1358B6AA76B6

Q28258066-40EFBE4B-8353-4F9E-A2FB-ADBB11C80575

Q28258066-42F43E37-4D8D-484C-A380-40C006676FD1

Q28258066-50EBCEFA-1941-4508-97AB-3C559B0C362A

Q28258066-60011F8A-7D97-479D-BA81-939AC59207A6

Q28258066-7044FA0C-3CC3-473E-97A1-99FF1642DA62

P304

Q28258066-A11D6AC2-F67E-4E4D-9067-75E72B1BC1AE

P31

Q28258066-75A77272-5B05-4743-9329-B5C1001FA9A6

P3181

Q28258066-A53611F8-0960-47F7-991A-C5E1553B0334

P356

Q28258066-8B030C77-FFE8-45D1-9D07-131B8C709784

P407

Q28258066-4ECC6BB3-2B27-4375-9D40-8922C18055CE

P433

Q28258066-93CE5C42-F7F8-4A7F-9B0B-7C61A12F4313

P478

Q28258066-FCE8B5F6-FB8B-4F66-BCE7-B5B38AF3BF2E

P50

Q28258066-04AE44BE-B546-4B5B-8AC4-04AD9675D442

Q28258066-AB38B630-4FD2-4936-B52D-54F96819A1C5

Q28258066-AC467384-7132-4709-B984-AAC5177B6BD7

P577

Q28258066-3BFF3E2C-D654-4A75-A19B-BCE92DFA83D9

P5875

Q28258066-C484DD74-8FD0-451B-B792-B7573B6657BB

P698

Q28258066-E44D41EA-4547-4103-A894-CDF5D69244BE

P921

Q28258066-1B383D41-814A-4266-8581-3CA15749B929

Q28258066-22633B0B-8430-4F02-9403-531EB8C6F802

Q28258066-5A50ADE1-6A65-4322-8A0E-7DFED4A14D5D

P3181

P356

P1433

Alimentary Pharmacology & Therapeutics

P1476

Randomised clinical trial: fae ...... lostridium difficile infection

@en

P2093

A Gasbarrini

http://www.w3.org/2001/XMLSchema#string

G Cammarota

http://www.w3.org/2001/XMLSchema#string

G Costamagna

http://www.w3.org/2001/XMLSchema#string

G Dinoi

http://www.w3.org/2001/XMLSchema#string

G Ianiro

http://www.w3.org/2001/XMLSchema#string

P2860

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

Duodenal infusion of donor feces for recurrent Clostridium difficile

Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study.

Fidaxomicin versus vancomycin for Clostridium difficile infection.

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection.

P304

835-843

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

841442

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/APT.13144

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Sanguinetti

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273065713

http://www.w3.org/2001/XMLSchema#string

P698

25728808

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile